Article
Successful management of delayed-onset adenosine deaminase deficiency with novel mutation.
Personalized medicine - 1 Jan 2024
Çelik Figen Çelebi, Soyöz Özgen, Bölük Selime Özen, Taşkırdı İlke, Hacı İdil Akay, Kaya Mehmet Şirin, Demir Ayça, Uzunoğlu Berna, Yıldırım Ayşen Türedi, Onay Hüseyin, Gözmen Salih, Gülez Nesrin, Genel Ferah
Abstract excerpt
A 4-year-old boy presented with acute-onset autoimmune cytopenia with severe, persistent lymphopenia, autoimmune thyroiditis, elevated IgE and glucose 6-phosphate dehydrogenase enzyme deficiency. In immunologic evaluation, lower T, B and natural killer cells and higher levels of adenosine deaminase (ADA) metabolites were observed. The compound heterozygous novel ADA gene mutations causing ADA deficiency were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
